120
Participants
Start Date
March 1, 2025
Primary Completion Date
July 31, 2025
Study Completion Date
July 31, 2025
Ripasudil
"Glanatec Ophthalmic Solution 0.4% W/V with ripasudil hydrochloride hydrate as active ingredient is currently being used by patients with ocular hypertension or open-angle glaucoma.~Inhibition of Rho kinase to facilitate aqueous outflow from the conventional outflow pathway via the trabecular meshwork and Schlemm's canal has been suggested as the IOP-lowering mechanism of action by ripasudil."
Placebo
Saline eye drops
RECRUITING
Singapore National Eye Centre, Singapore
Singapore Eye Research Institute
OTHER